Topics
Fair Isaac and Broadridge were well positioned to gain during the pandemic: since March of 2020, Fair Isaac is up 150.7%, and Broadridge has jumped 98.1%. We think both stocks have room to move even higher as their products continue to experience strong—and growing —demand.


FAIR ISAAC CORP., $438.80, is a buy. The company (New York symbol FICO; TSINetwork Rating: Average) (www.fairisaac.com; Shares outstanding: 27.4 million; Market cap: $11.9 billion; No dividends paid) is best known for its FICO Scores software....
Restaurant Brands acquired a top asset when it bought Popeyes Louisiana Kitchen in 2017 for $1.64 billion. And a big part of the appeal was the potential for Popeyes to expand further in the U.S. and internationally. Restaurant Brands first focused on U.S. expansion, but now it’s adding more foreign markets.


RESTAURANT BRANDS INTERNATIONAL, $56.17, is a buy. The company (New York symbol QSR; TSI Rating: Average) (www.rbi.com; Shares o/s: 478.0 million; Market cap: $26.8 billion; Yield: 3.8%) continues to expand Popeyes globally.


This includes its just-announced plan to develop and grow the Popeyes brand in South Korea....
Long-time readers know that we keep you informed of important news about the stocks we cover. That means highlighting developments and plans that promise to brighten prospects for investors. Here are two buys that stand out this month:


ADOBE INC., $516.58, is a buy. The company (Nasdaq symbol ADBE; TSINetwork Rating: Average) (www.adobe.com; Shares o/s: 475.8 million; Market cap: $244.3 billion; No dividends paid) reports that in the three months ended December 3, 2021, revenue shot up 20.0%, to $4.11 billion from $3.42 billion....
CHIPOTLE MEXICAN GRILL, $1,467.68, is a buy. The chain (New York symbol CMG; TSINetwork Rating: Extra Risk) (www.chipotle.com; Shares o/s: 28.1 million; Market cap: $41.6 billion; No divd.) is now selling its own plant-based chorizo (pork sausage) U.S.-wide after a trial run last year....
Yamana Gold and IAMGold offer you ways to prosper from rising precious metal prices—amid ongoing coronavirus uncertainty but also well beyond it. Today’s economic volatility should significantly boost demand for gold as an investment, especially if huge government stimulus spending spurs inflation and sends investors into gold as a “store of value.” Both stocks are buys.


YAMANA GOLD, $5.55, is a buy. The company (Toronto symbol YRI; TSINetwork Rating: Speculative) (www....

COMPUTER MODELLING GROUP, $4.40, is still a buy. The company (Toronto symbol CMG; TSINetwork Rating: Extra Risk) (www.cmgl.ca; Shares o/s 80.3 million; Market cap: $353.5 million; Dividend yield: 4.6%) reports that in the three months ended September 30, 2021, its revenue fell 10.7%, to $15.9 million from $17.9 million a year earlier....
First, the good news: widening cannabis legalization will eventually lead to some great business successes. The bad news is that only a few of the multitude of cannabis stocks today will pay off for investors. Consumer cannabis demand is high, but growing and distributing it across multiple markets is more difficult....
DRAFTKINGS INC., $21.40, is a buy. The company (Nasdaq symbol DKNG; TSINetwork Rating: Extra Risk) (www.draftkings.com; Shares o/s: 789.3 million; Market cap: $17.7 billion; No dividend) launched its mobile and online sportsbook in New York on January 8, 2022....
Twilio benefited from increased demand during the pandemic. But its business model and leading-edge technology also set it up for longer-term success. We recommend this stock as a Power Buy.


TWILIO INC., $203.69, is a buy. The company (Nasdaq symbol TWLO; TSINetwork Rating: Extra Risk) (www.twilio.com; Shares outstanding: 168.4 million; Market cap: $37.0 billion; No dividends paid) offers a key service to software developers who create mobile apps....
RESMED INC., $241.39 (New York symbol RMD; TSINetwork Rating: Average)(www.resmed.com; Shares outstanding: 145.7 million; Market cap: $35.1 billion; Dividend yield: 0.7%) was a #1 Power Buy for 2021 at $217.96. The shares reached as high as $301.34 in September (up 38.3%), before drifting down to today’s price (for a gain of 10.7%).


We think the shares can regain last year’s all-time high—and move higher.


ResMed continues to prosper in its core market—medical devices used to treat sleep apnea....